The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50 instead of 60 ...

A group of mothers in Victoria say they've experienced trouble accessing the jab for a highly infectious illness that infects ...

Health Secretary Robert F. Kennedy Jr. endorsed the expanded use of RSV vaccines for people 50 through 59 years old who are ...

The new RSV recommendation calls for a single dose of vaccine for adults age 50 to 59 years who are at increased risk of ...

Shares of Moderna MRNA rose nearly 6% yesterday after the U.S. Centers for Disease Control and Prevention (“CDC”) adopted new ...

The ACIP is recommending the use of Enflonsia for the prevention of RSV lower respiratory tract disease in infants younger than 8 months.

Follow the latest RSV cases news stories and headlines. Get breaking news alerts when you download the ABC News App and subscribe to RSV cases notifications.

A newly approved shot could soon help protect babies from respiratory syncytial virus (RSV), the top cause of hospitalization in U.S. infants.

Moderna's RSV vaccine gets expanded approval for 18-59 year olds at high risk of severe illness, marking a significant step in vaccine protection.

The Food and Drug Administration (FDA) has expanded the approval of mResvia (respiratory syncytial virus [RSV] vaccine) to include active immunization in individuals 18 through 59 years of age who ...

The simplicity of the new monoclonal Enflonsia could give it an advantage over AstraZeneca’s Beyfortus Enflonsia, a monoclonal antibody for RSV, is approved for use in children under 12 months ...